β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and ChemoresistanceTobias Sinnberg, Birgit Schittek|PLoS ONE|2011Cited by 108
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseCorinna Kosnopfel, Birgit Schittek|Oncotarget|2017Cited by 48
Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibitionElena Makino, Birgit Schittek|Cell Death and Disease|2020Cited by 29
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitisJasmin Scheurer, Birgit Schittek|Disease Models & Mechanisms|2024Cited by 18
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction <i>In Vitro</i> and <i>In Vivo</i>Lisa Marie Fröhlich, Birgit Schittek|Cancer Research Communications|2023Cited by 15